Beta-lactamase-producing bacteria
3 drugsPredictive biomarker for patient selection in 5 indications
3
Approved Drugs
5
Indications
1
Companies
Beta-lactamase-producing bacteria is a precision-medicine biomarker linked to 3 FDA-approved targeted drugs from 1 company, spanning 5 indications including Lower Respiratory Tract Infection, Acute Bacterial Otitis Media, Sinusitis. Explore the targeted therapies, indications, testing methods, and companies developing Beta-lactamase-producing bacteria drugs below.
Search Beta-lactamase-producing bacteria Clinical Trials
Search recruiting trials on ClinicalTrials.gov
Drugs Targeting Beta-lactamase-producing bacteria
| Drug | Company | Therapeutic Area |
|---|---|---|
| AUGMENTIN '125' | US ANTIBIOTICS | Infectious Disease |
| AUGMENTIN '250' | US ANTIBIOTICS | Infectious Disease |
| AUGMENTIN '875' | US ANTIBIOTICS | Infectious Disease |